Skip to content
healthcare.dev

Trientine Hydrochloride

NDC 16571-812, Trientine Hydrochloride, capsule, from Rising Pharma Holdings, Inc..

Product NDC
16571-812
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212238
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIENTINE HYDROCHLORIDE500 mg/1

Pharmacologic classes

Copper Chelating Activity [MoA]; Copper Chelator [EPC]; Metal Chelating Activity [MoA]

Package NDCNDC-11Package
16571-812-051657108120550 CAPSULE in 1 BOTTLE (16571-812-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f33c1322-f7c0-4684-afc8-8caa3f4023dc

Use it

Look up 16571-812 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-812 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-812. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.